Xiaoyu Xu

487 total citations
20 papers, 334 citations indexed

About

Xiaoyu Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaoyu Xu has authored 20 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Xiaoyu Xu's work include MicroRNA in disease regulation (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xiaoyu Xu is often cited by papers focused on MicroRNA in disease regulation (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xiaoyu Xu collaborates with scholars based in China, Finland and United States. Xiaoyu Xu's co-authors include Songcheng Yin, Shan Gao, Jin Zhang, Baishi Wang, Ying Zhang, Shanshan Xie, Yongyi Yu, Yulong He, Tian Li and Pengliang Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Advanced Science.

In The Last Decade

Xiaoyu Xu

19 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoyu Xu China	11	157	80	73	55	49	20	334
Tongsheng Wang China	10	226 1.4×	108 1.4×	58 0.8×	19 0.3×	39 0.8×	48	481
Ana Paula Fernandes Barbosa Brazil	8	89 0.6×	73 0.9×	34 0.5×	81 1.5×	19 0.4×	21	409
Chengfang Yao China	11	130 0.8×	35 0.4×	32 0.4×	56 1.0×	112 2.3×	21	336
Yanlong Wang China	10	197 1.3×	81 1.0×	24 0.3×	35 0.6×	19 0.4×	29	343
Tomo Suga Japan	11	106 0.7×	56 0.7×	40 0.5×	30 0.5×	8 0.2×	15	238
Ling Lv China	11	168 1.1×	46 0.6×	32 0.4×	33 0.6×	23 0.5×	19	318
Xiuhua Hu China	10	170 1.1×	83 1.0×	21 0.3×	43 0.8×	79 1.6×	19	329
Haiyan Du China	11	234 1.5×	128 1.6×	11 0.2×	49 0.9×	35 0.7×	22	346
Kristin M. Bircsak United States	13	132 0.8×	40 0.5×	22 0.3×	147 2.7×	19 0.4×	24	480

Countries citing papers authored by Xiaoyu Xu

Since Specialization

Citations

This map shows the geographic impact of Xiaoyu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyu Xu more than expected).

Fields of papers citing papers by Xiaoyu Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyu Xu. The network helps show where Xiaoyu Xu may publish in the future.

Co-authorship network of co-authors of Xiaoyu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyu Xu. A scholar is included among the top collaborators of Xiaoyu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyu Xu. Xiaoyu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Shengyi, Xiaoyu Xu, Tapani Viitala, Yilai Shu, & Hongbo Zhang. (2025). Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors. Molecular Therapy — Nucleic Acids. 36(4). 102737–102737.

Zhou, Wenhui, Xiaodong Ma, Jianpeng Xiao, et al.. (2024). Exploiting the Warburg Effect: Co‐Delivery of Metformin and FOXK2 siRNA for Ovarian Cancer Therapy. SHILAP Revista de lepidopterología. 4(3). 2300192–2300192. 9 indexed citations

Yin, Songcheng, Huifang Liu, Zhijun Zhou, et al.. (2023). PUM1 Promotes Tumor Progression by Activating DEPTOR‐Meditated Glycolysis in Gastric Cancer. Advanced Science. 10(27). e2301190–e2301190. 17 indexed citations

Xu, Xiaoyu, Songcheng Yin, Yun Wang, et al.. (2023). LILRB1+ immune cell infiltration identifies immunosuppressive microenvironment and dismal outcomes of patients with ovarian cancer. International Immunopharmacology. 119. 110162–110162. 10 indexed citations

Xianyu, Yunyan, et al.. (2022). One‐year follow‐up of 18 women who infected COVID‐19 while pregnant. Journal of Medical Virology. 94(5). 2302–2306. 3 indexed citations

Liu, Huifang, Jing Wu, Xiaoyu Xu, et al.. (2022). Peritumoral TIGIT+CD20+ B cell infiltration indicates poor prognosis but favorable adjuvant chemotherapeutic response in gastric cancer. International Immunopharmacology. 108. 108735–108735. 25 indexed citations

Li, Mengxiong, et al.. (2021). A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer. Brazilian Journal of Medical and Biological Research. 54(11). e11592–e11592. 9 indexed citations

Pan, Zhimin, Fengbo Mo, Hucheng Liu, et al.. (2021). LncRNA prostate androgen-regulated transcript 1 (PART 1) functions as an oncogene in osteosarcoma via sponging miR-20b-5p to upregulate BAMBI. Annals of Translational Medicine. 9(6). 488–488. 4 indexed citations

Zhang, Yawei, Han Wang, Xiaoyu Xu, et al.. (2021). Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients. Frontiers in Oncology. 11. 668707–668707. 13 indexed citations

10.

Di, Lei, Chen Wang, Chunyan Li, et al.. (2020). Clinical characteristics of COVID-19 in pregnancy: analysis of nine cases. Zhonghua weichan yixue zazhi. 23(3). 222–228. 36 indexed citations

11.

Meng, Dandan, Xin Liu, Xi Cheng, et al.. (2020). RIGD: A Database for Intronless Genes in the Rosaceae. Frontiers in Genetics. 11. 868–868. 5 indexed citations

12.

Gao, Shan, Baishi Wang, Shanshan Xie, et al.. (2020). A high-quality reference genome of wild Cannabis sativa. Horticulture Research. 7(1). 73–73. 78 indexed citations

13.

Hu, Wei, et al.. (2020). Long noncoding RNA FOXD2‐AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR‐206/MAP3K1 axis. Cancer Medicine. 9(15). 5620–5631. 16 indexed citations

14.

Xu, Xiaoyu, Songcheng Yin, Mengxiong Li, et al.. (2019). <p>Comparative efficacy of targeted maintenance therapy for newly diagnosed epithelial ovarian cancer: a network meta-analysis</p>. Cancer Management and Research. Volume 11. 4119–4128. 2 indexed citations

15.

Yin, Songcheng, Pengliang Wang, Xiaoyu Xu, et al.. (2019). The optimal strategy of multimodality therapies for resectable gastric cancer: evidence from a network meta-analysis. Journal of Cancer. 10(14). 3094–3101. 9 indexed citations

16.

Xia, Lijie, et al.. (2019). The Extracts of Artemisia absinthium L. Suppress the Growth of Hepatocellular Carcinoma Cells through Induction of Apoptosis via Endoplasmic Reticulum Stress and Mitochondrial-Dependent Pathway. Molecules. 24(5). 913–913. 17 indexed citations

17.

Li, Tian, Mengxiong Li, Chengfang Xu, et al.. (2019). miR‑146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NF‑κB signaling by targeting TRAF6. Oncology Reports. 41(5). 2897–2908. 23 indexed citations

18.

Yin, Songcheng, Zhi‐Feng Miao, Yuen Tan, et al.. (2019). SPHK1‐induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination. Cancer Medicine. 8(4). 1731–1743. 25 indexed citations

19.

Xu, Xiaoyu, et al.. (2019). Genome Sequence of Lactobacillus futsaii Y97, a Potential Probiotic Strain Isolated from Futsai of Taiwan. Microbiology Resource Announcements. 8(39). 2 indexed citations

20.

Xu, Xiaoyu, et al.. (2017). MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance. Cancer Biomarkers. 19(2). 221–230. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact